Could a new drug sharpen the minds of people with schizophrenia?
Symptom relief
Not yet recruiting
This study tests whether a new medicine, Xanomeline/Trospium (also called KarXT), can improve thinking and memory in adults with schizophrenia. Unlike standard antipsychotics, this drug targets a different brain system and may help with cognitive symptoms. Researchers will follow…
Phase: PHASE3 • Sponsor: European Group for Research In Schizophrenia • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC